We have isolated 165 Caenorhabditis elegans mutants, representing 21 Synaptic transmission is a major mechanism for intercellular communication in the nervous system. Many of the events that mediate synaptic transmission occur presynaptically and center on the synaptic vesicle cycle. The major steps of the synaptic vesicle cycle were described 20-40 years ago by investigators using electrophysiology and electron microscopy (reviewed in refs. 1-3). In brief, neurons produce specialized vesicles that are transported down axons to synaptic sites, where they are filled with neurotransmitter and stored in clusters. A small fraction of the vesicles become docked at active zones on the presynaptic membrane. The arrival of an electrical signal at the synapse induces the opening of voltage-gated calcium channels, and the resulting influx of calcium leads to the fusion of some of the docked synaptic vesicles with the plasma membrane and the release of neurotransmitter into the synaptic cleft. Transmission of the chemical signal is completed when the neurotransmitter binds postsynaptic receptors. The cycle continues in the presynapse with the docking of additional vesicles and the local recycling of fused vesicle membrane by endocytosis. Over the past 15 years, a molecular description of the synaptic vesicle cycle has begun to emerge. Biochemical and molecular studies have been important for the identification and analysis of many presynaptic proteins (reviewed in refs. 4-6) and have illuminated the roles of some of these proteins in the synaptic vesicle cycle.Classical genetic approaches using invertebrates have complemented biochemical studies by identifying additional presynaptic components and by allowing assessment of the function and importance of individual proteins (7)(8)(9)(10)(11)(12) While it has been known for some time that certain C. elegans uncoordinated (Unc) mutants are resistant to AChE inhibitors (13-17), the use of genetic screens to select for Ric mutants directly has thus far resulted in the isolation of mutations in only 6 genes (13,18 4These studies were begun while A

Mutations in the unc-17 gene of the nematode Caenorhabditis elegans produce deficits in neuromuscular function. This gene was cloned and complementary DNAs were sequenced. On the basis of sequence similarity to mammalian vesicular transporters of biogenic amines and of localization to synaptic vesicles of cholinergic neurons in C. elegans, unc-17 likely encodes the vesicular transporter of acetylcholine. Mutations that eliminated all unc-17 gene function were lethal, suggesting that the acetylcholine transporter is essential. Molecular analysis of unc-17 mutations will allow the correlation of specific parts of the gene (and the protein) with observed functional defects. The mutants will also be useful for the isolation of extragenic suppressors, which could identify genes encoding proteins that interact with UNC-17.

The unc-11 gene of Caenorhabditis elegans encodes multiple isoforms of a protein homologous to the mammalian brain-specific clathrin-adaptor protein AP180. The UNC-11 protein is expressed at high levels in the nervous system and at lower levels in other tissues. In neurons, UNC-11 is enriched at presynaptic terminals but is also present in cell bodies. unc-11mutants are defective in two aspects of synaptic vesicle biogenesis. First, the SNARE protein synaptobrevin is mislocalized, no longer being exclusively localized to synaptic vesicles. The reduction of synaptobrevin at synaptic vesicles is the probable cause of the reduced neurotransmitter release observed in these mutants. Second,unc-11 mutants accumulate large vesicles at synapses. We propose that the UNC-11 protein mediates two functions during synaptic vesicle biogenesis: it recruits synaptobrevin to synaptic vesicle membranes and it regulates the size of the budded vesicle during clathrin coat assembly.

How genetic and environmental factors interact in Parkinson disease is poorly understood. We have now compared the patterns of vulnerability and rescue of Caenorhabditis elegans with genetic modifications of three different genetic factors implicated in Parkinson disease (PD). We observed that expressing ␣-synuclein, deleting parkin (K08E3.7), or knocking down DJ-1 (B0432.2) or parkin produces similar patterns of pharmacological vulnerability and rescue. C. elegans lines with these genetic changes were more vulnerable than nontransgenic nematodes to mitochondrial complex I inhibitors, including rotenone, fenperoximate, pyridaben, or stigmatellin. In contrast, the genetic manipulations did not increase sensitivity to paraquat, sodium azide, divalent metal ions (Fe(II) or Cu(II)), or etoposide compared with the nontransgenic nematodes. Each of the PD-related lines was also partially rescued by the antioxidant probucol, the mitochondrial complex II activator, D-␤-hydroxybutyrate, or the anti-apoptotic bile acid tauroursodeoxycholic acid. Complete protection in all lines was achieved by combining D-␤-hydroxybutyrate with tauroursodeoxycholic acid but not with probucol. These results show that diverse PD-related genetic modifications disrupt the mitochondrial function in C. elegans, and they raise the possibility that mitochondrial disruption is a pathway shared in common by many types of familial PD.The etiology of Parkinson disease has both genetic and environmental components (1). Epidemiological studies show that PD 3 is more common in rural areas, and increased rates of PD are associated with the use of agricultural toxins, such as pesticides and herbicides (2). Attention has focused on inhibitors of the mitochondrial electron transport chain because some of the agricultural toxins implicated in PD are complex I inhibitors (2). In addition, ingestion of complex I inhibitors causes syndromes related to PD. The complex I inhibitor 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) selectively kills dopaminergic neurons in many types of animals (1). Rotenone, another complex I inhibitor, also causes a PD-related syndrome in rats and causes multiple changes in the mitochondria of cultured neurons relevant to PD (3-6). These factors implicate disruption of mitochondrial function, and particularly complex I inhibition, in the etiology of PD.Many of the genes associated with familial cases of PD have been identified, but no clear consensus exists over whether the different disease-related proteins converge onto a common pathway. Mutation of ␣-synuclein (at A53T, A30P, or K46E) or duplication of ␣-synuclein is associated with familial parkinsonisms (7-10). Loss of the putative ubiquitin ligase, parkin, causes autosomal recessive juvenile parkinsonism (11). Mutations in the genes coding for UCH-L1, DJ-1, and PINK1 are also all associated with autosomal recessive PD, and mutations in LRRK2 are associated with autosomal dominant PD (12-15). ␣-Synuclein is a small ubiquitous protein that binds lipids and might regulate ves...

The fluorescent probe FM1-43 has been used extensively for imaging vesicle recycling; however, high nonspecific adsorption resulting in elevated background levels has precluded its use in certain tissues, notably brain slices. We have found that a sulfobutylated derivative of beta-cyclodextrin (ADVASEP-7) has a higher affinity for FM1-43 than the plasma membrane. ADVASEP-7 was used as a carrier to remove FM1-43 nonspecifically bound to the outer leaflet of the plasma membrane or extracellular molecules, significantly reducing background staining. This has enabled us to visualize synaptic vesicle recycling in the nematode C. elegans, intact lamprey spinal cord, and rat brain slices.